Art

J-GLOBAL ID：201902204483428093   Reference number：19S1261309

Multicenter phase II study of lenalidomide in relapsed or recurrent adult T-cell leukemia/lymphoma: ATLL-002

Author (18)： Ishida, Takashi (Department of Hematology and Oncology, Nagoya City University, Graduate School of Medical Sciences) ,  Fujiwara, Hiroshi (Ehime University Hospital) ,  Nosaka, Kisato (Kumamoto University Hospital) ,  Taira, Naoya (Heart Life Hospital) ,  Abe, Yasunobu (Kyushu Cancer Center) ,  Imaizumi, Yoshitaka (Nagasaki University Hospital) ,  Moriuchi, Yukiyoshi (Sasebo City General Hospital) ,  Jo, Tatsuro (Japanese Red Cross Nagasaki Genbaku Hospital) ,  Ishizawa, Kenichi (Tohoku University Hospital) ,  Tobinai, Kensei (National Cancer Center Hospital) ,  Midorikawa, Shuichi (Celgene K.K.) ,  Ruiz, Wanda (Celgene K.K.) ,  Ohtsu, Tomoko (Celgene K.K.) ,  Tsukasaki, Kunihiro (National Cancer Center Hospital East) ,  Ito, Shigeki (Iwate Medical University) ,  Yoshimitsu, Makoto (Kagoshima University Hospital) ,  Otsuka, Maki (National Hospital Organization, Kagoshima Medical Center) ,  Ogura, Michinori (Tokai Central Hospital)
Material： Journal of Clinical Oncology
Volume： 34  Issue： 34  Page： 4086-4093  Publication year： 2016 
JST Material Number： SCOPUS  ISSN： 0732-183X  CODEN： JCOND 
Country of issue： United States (USA)  Language： English (EN)